A randomized clinical study on efficacy of Aidi injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 7, Issue 3, 2004, Pages 247-249

  Wang, Dijin ^a   Chen, Yinglan ^a   Ren, Jian ^a   Cai, Yun ^a   Liu, Minzhi ^a   Zhan, Qinyuan ^a  

^a Jiangxi Provincial Cancer Hospital   (China)

Author keywords

Aidi Injection; Chemotherapy; Immune function; Non small cell lung cancer; Toxic and adverse reaction

Indexed keywords

AIDI; ANTINEOPLASTIC AGENT; ASTRAGALUS MEMBRANACEUS EXTRACT; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CISPLATIN; NAVELBINE; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; HUMAN; IMMUNE SYSTEM; INJECTION; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; TREATMENT OUTCOME;

EID: 3042663021     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Sun Y, Zhou JC. Handbook of medical oncology. 3rd ed. Beijing: People's Medical Publishing House, 1996. 30-34.
2. Yang H. Synergistic inhibition of ginsenoside and immune ribonucleic acid to expression of oncogene. J Chin Med Univ, 1992, 2(2): 51-52.
3. Ma D. Preliminary study on inhibition of astragalus root and acanthopanax root on human oophoroma, Tumor, 1992, 2(2): 51-52.
4. Xiong SY, Jin YL, Ren HX. Anticancer experimental study and clinical status of astragalus root. Lishizhen Med Med Res, 1999, 10 (9): 705-706.
5. Fang Y. Anti-tumor medicine research. Synthesization and anticancer activity of desmethylcantharidin deoxy dehydro analog. Acta Pharmaceutica Sinica, 1993, 28(12): 931-935.